Effects of etanercept on sodium taurocholate-induced acute pancreatitis in rats

Translational Research

Volumn 154, Issue 5, 2009, Pages 241-249

  Yilmaz, Mustafa ^a   Topsakal, Senay ^a   Herek, Ozkan ^a   Ozmen, Ozlem ^b   Sahinduran, Sima ^b   Buyukoglu, Tulay ^b   Yonetci, Nadir ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b MEHMET AKIF ERSOY UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; CASPASE; ETANERCEPT; MALONALDEHYDE; MYELOPEROXIDASE; TAUROCHOLIC ACID; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM;

AMYLASES; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CHOLAGOGUES AND CHOLERETICS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LIPASE; MALONDIALDEHYDE; NECROSIS; PANCREAS; PANCREATITIS, ACUTE NECROTIZING; PEROXIDASE; RATS; RATS, WISTAR; RECEPTORS, TUMOR NECROSIS FACTOR; TAUROCHOLIC ACID;

EID: 70349943976     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2009.07.009     Document Type: Article

References (34)

1. Yamauchi J., Shibuya K., Sunamura M., et al. Cytokine modulation in acute pancreatitis. J Hepatobil Pancreat Surg 8 (2001) 195-203
2. Paran H., Mayo A., Kidron D., et al. Experimental acute necrotising pancreatitis: evaluation and characterisation of a model of intraparenchymal injection of sodium taurocholate in rats. Eur J Surg 166 (2000) 894-898
3. Gulcubuk A., Sonmez K., Gurel A., et al. Pathologic alterations detected in acute pancreatitis induced by sodium taurocholate in rats and therapeutic effects of curcumin, ciprofloxacin and metronidazole combination. Pancreatology 5 (2005) 345-353
4. Old L.J. Tumor necrosis factor. Sci Am 258 (1988) 59-75
5. Zhou H. Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein. J Clin Pharmacol 45 (2005) 490-497
6. McKay C., Gallagher G., Baxter J.N., and Imrie C.W. Systemic complications in acute pancreatitis are associated with increased monocyte cytokine release. Gut 35 (1994) 575
7. Norman J.G., Fink M.D., and Franz M.D. Acute pancreatitis indices intrapancreatic tumor necrosis factor gene expression. Arch Surg 130 (1995) 966-970
8. Grewal H., Kotb M., el Din A.M., et al. Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 115 (1994) 213-221
9. Hughes C.B., Grewall H.P., Gaber L.W., et al. Anti-TNF therapy improves survival and ameliorates the pathophysiolgic sequelae in acute pancreatitis in the rat. Am J Surg 171 (1996) 274-280
10. Choy E.H., and Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344 (2001) 907-916
11. Maini R.N., and Taylor P.C. Anti-cytokine therapy for rheumatoid arthritis. Annu Rev Med 51 (2000) 207-229
12. Llopis S.P., Ferrando M.D., and Pena J.B. Fish tolerance to organophosphate induced oxidative stress is dependent on the glutathione metabolism and enhanced by N-acetylcysteine. Aquat Toxicol 65 (2003) 337-360
13. Rau B., Bauer A., Wang A., et al. Modulation of endogenous nitric oxide syntheses in experimental acute pancreatitis: role of anti-ICAM-1 and oxygen free radical scavengers. Ann Surg 233 (2001) 195-203
14. Chan Y.C., and Leung P.S. Acute pancreatitis, animal models and recent advances in basic research. Pancreas 34 (2007) 1-14
15. Luna L.G. Methods for carbohydrates and mucoproteins. Manual of histologic staining methods of the armed forces institute of pathology (1968), McGraw-Hill, New York 76
16. Ahmed S.H., He Y.Y., Nassief A., Xu J., Xu X.M., and Hsu C.Y. Effects of lipopolysaccharide priming on acute ischemic brain injury. Stroke 31 (2000) 193-199
17. Tullis M.J., Brown S., and Gewertz B.L. Hepatic influence on pulmonary neutrophil sequestration following intestinal ischemia-reperfusion. J Surg Res 66 (1996) 143-146
18. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95 (1979) 351-358
19. Schmidt J., Rattner D.W., Lewandrowski K., et al. A better model of acute pancreatitis for evaluating therapy. Ann Surg 215 (1992) 44-56
20. Shields C.J., Winter D.C., Sookhai S., Ryan L., Kirwan W.O., and Redmond H.P. Hypertonic saline attenuates end-organ damage in an experimental model of acute pancreatitis. Br J Surg 87 (2000) 1336-1340
21. Hirota M., Nozawa F., Okabe A., et al. Relationship between plasma cytokine concentration and multiple organ failure in patient with acute pancreatitis. Pancreas 21 (2000) 141-146
22. Laveda R., Martinez J., Munoz C., et al. Different profile of cytokine synthesis according to the severity of acute pancreatitis. World J Gastroenterol 11 (2005) 5309-5313
23. Zhang X.P., Lin Q., and Zhou Y.F. Progress of study on the relationship between mediators of inflammation and apoptosis in acute pancreatitis. Dig Dis Sci 52 (2007) 1199-1205
24. Tsujimoto M., Yokota S., Vileck J., and Weissmann G. Tumor necrosis factor provokes superoxide generation from neutrophils. Biochem Biophys Res 37 (1986) 1094-1099
25. De Almeida J.L.J., Jukemura J., Coelho A.M.M., Patzina R.A., Machado M.C.C., and Cunha J.E.M. Inhibition of cyclooxygenase-2 in experimental severe acute pancreatitis. Clinics 61 (2006) 301-306
26. Norman J.G., Fink G.W., Messina Carter G., and Franz M.G. Timing of tumor necrosis factor antagonism is a critical in determining outcome in murine lethal acute pancreatitis. Surgery 120 (1996) 515-521
27. Oruc N., Ozutemiz O., Yukselen V., et al. Infliximab: a new therapeutic agent in acute pancreatitis. Pancreas 28 (2004) 1-8
28. Qin H.L., Su Z.D., Hu L.G., Ding Z.X., and Lin Q.T. Parenteral versus early intrajejunal nutrition: effects on pancreatitic natural course, entero-hormones release and its efficacy on dogs with acute pancreatitis. World J Gastroenterol 9 (2003) 2270-2273
29. Sanfey H., Bulkley G.B., and Cameron J.L. The pathogenesis of acute pancreatitis. Ann Surg 201 (1985) 633-639
30. Genovese T., Mazzon E., Di Paola R., et al. Hypericum perforatum attenuates the development of cerulein-induced acute pancreatitis in mice. Shock 25 (2006) 161-167
31. Cuzzocrea S., Mazzon E., Dugo L., et al. Inducible nitric oxide synthase-deficient mice exhibit resistance to the acute pancreatitis induced by cerulein. Shock 17 (2002) 416-422
32. Ward J.B., Sutton R., Jenkins S.A., et al. Progressive disruption of acinar cell calcium signaling is an early feature of cerulein-induced pancreatitis in mice. Gastroenterology 111 (1996) 481-491
33. Malleo G., Mazzon E., Genovese T., et al. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-α genetic deletion. Shock 27 (2007) 542-551
34. Buscaglia J.N., Simons B.W., Prosser B.J., et al. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines. JOP 9 (2008) 456-467